CELEX: 22019D0736
Language: en
Date: 2017-07-07 00:00:00
Title: Decision of the EEA Joint Committee No 129/2017 of 7 July 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/736]

16.5.2019   
               
               
                  EN
               
               
                  Official Journal of the European Union
               
               
                  L 128/21
               
            
         DECISION OF THE EEA JOINT COMMITTEE
         No 129/2017
         of 7 July 2017
         amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/736]
         THE EEA JOINT COMMITTEE,
         Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
         Whereas:
         
                     (1)
                  
                  
                     Commission Implementing Regulation (EU) No 699/2014 of 24 June 2014 on the design of the common logo to identify persons offering medicinal products for sale at a distance to the public and the technical, electronic and cryptographic requirements for verification of its authenticity (1) is to be incorporated into the EEA Agreement.
                  
               
                     (2)
                  
                  
                     Annex II to the EEA Agreement should therefore be amended accordingly,
                  
               HAS ADOPTED THIS DECISION:
         
            Article 1
            The following point is inserted after point 18 (Regulation (EU) No 536/2014 of the European Parliament and of the Council) of Chapter XIII of Annex II to the EEA Agreement:
            
                        ‘19.
                     
                     
                        
                           32014 R 0699: Commission Implementing Regulation (EU) No 699/2014 of 24 June 2014 on the design of the common logo to identify persons offering medicinal products for sale at a distance to the public and the technical, electronic and cryptographic requirements for verification of its authenticity (OJ L 184, 25.6.2014, p. 5).’
                     
                  
         
            Article 2
            The text of Implementing Regulation (EU) No 699/2014 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
         
         
            Article 3
            This Decision shall enter into force on 8 July 2017, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
         
         
            Article 4
            This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
         
         
            Done at Brussels, 7 July 2017.
            
               
                  For the EEA Joint Committee
               
               
                  The President
               
               Sabine MONAUNI
            
         
         
            (1)  OJ L 184, 25.6.2014, p. 5.
         
            (*1)  Constitutional requirements indicated.